CD20+ Follicular Lymphoma
1 clinical trials · Condition
◉ Watch CD20+ Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO) (NCT02391545) | SecuraBio | 2014-12-01 |
Track CD20+ Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.